Evotec (OTCMKTS:EVTCY) Hits New 12-Month Low at $4.89

Evotec SE (OTCMKTS:EVTCY)’s share price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $4.89 and last traded at $4.95, with a volume of 31345 shares. The stock had previously closed at $4.86.

Evotec Stock Performance

The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of 12.07 and a beta of 0.98. The company’s 50-day simple moving average is $4.91 and its 200-day simple moving average is $7.09.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.